Farmers & Merchants Investments Inc. raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96,521 shares of the medical instruments supplier’s stock after buying an additional 2,000 shares during the period. Farmers & Merchants Investments Inc.’s holdings in DENTSPLY SIRONA were worth $6,258,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Howard Hughes Medical Institute raised its position in shares of DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 1,580 shares in the last quarter. Penserra Capital Management LLC raised its position in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 240 shares in the last quarter. Howland Capital Management LLC acquired a new position in shares of DENTSPLY SIRONA during the first quarter valued at $203,000. TNB Financial acquired a new position in shares of DENTSPLY SIRONA during the first quarter valued at $259,000. Finally, Rockefeller Financial Services Inc. acquired a new position in shares of DENTSPLY SIRONA during the second quarter valued at $273,000. Institutional investors and hedge funds own 95.13% of the company’s stock.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) traded down 0.60% on Friday, reaching $52.85. 1,573,864 shares of the company were exchanged. The stock’s market capitalization is $12.13 billion. The company’s 50-day moving average price is $61.35 and its 200-day moving average price is $62.19. DENTSPLY SIRONA Inc. has a 12-month low of $52.73 and a 12-month high of $65.68.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.65. The business had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.76 EPS. Equities research analysts anticipate that DENTSPLY SIRONA Inc. will post $2.69 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.66%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.
TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA Inc. (XRAY) Stake Increased by Farmers & Merchants Investments Inc.” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/18/farmers-merchants-investments-inc-increases-position-in-dentsply-sirona-inc-xray-updated-updated-updated.html.
XRAY has been the subject of several recent analyst reports. Goldman Sachs Group, Inc. (The) downgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and lowered their target price for the company from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a research note on Thursday, July 13th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. Finally, HC Wainwright began coverage on shares of DENTSPLY SIRONA in a research report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price objective for the company. Three analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $66.25.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
